Showing results (601-610 of 624) with videos related to

Sort By:
Pageof 63
The New England Journal of Medicine|May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating TherapyYao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2021
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastasesAnne Zaremba, Manuel Philip, Jessica C Hassel, et al.
Cancers|February 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or ToxicityElias A T Koch, Anne Petzold, Anja Wessely, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Nature Communications|August 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.
The Journal of Clinical Investigation|February 14, 2017
Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorderNoa Lipstein, Nanda M Verhoeven-Duif, Francesco E Michelassi, et al.
Science Advances|February 1, 2021
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidineAvani Yeola, Shruthi Subramanian, Rema A Oliver, et al.
Pageof 63